Oncology

Latest News

Putting LP-284 on the Industry RADR
Putting LP-284 on the Industry RADR

May 17th 2024

Panna Sharma, CEO of Lantern Pharma, discusses LP-284, using their RADR during testing, ensuring global use, and what the future holds.

Where Innovation and Patients Meet to Improve Cancer Care
Where Innovation and Patients Meet to Improve Cancer Care

May 16th 2024

Accelerating the Progress of Kinase Inhibitors in Oncology
Accelerating the Progress of Kinase Inhibitors in Oncology

May 14th 2024

In Focus: Rethinking the Complex Process for Cancer Trials
In Focus: Rethinking the Complex Process for Cancer Trials

May 14th 2024

Image credit: MdBabul | stock.adobe.com
Keytruda Combination Falls Short of Disease-Free Survival Primary Endpoint in Phase III Trial for High-Risk Endometrial Cancer

May 9th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.